{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:49:36Z","timestamp":1760147376691,"version":"build-2065373602"},"reference-count":68,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T00:00:00Z","timestamp":1674864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"University of Parma","award":["D.M. 737\/2021"],"award-info":[{"award-number":["D.M. 737\/2021"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>The BNT162b2 COVID-19 vaccine is composed of lipid-nanoparticles (LNP) containing the mRNA that encodes for SARS-CoV-2 spike glycoprotein. Bronchospasm has been reported as an early reaction after COVID-19 mRNA vaccines in asthmatic patients. The aim of this study was to investigate the acute impact of BNT162b2 in a human ex vivo model of severe eosinophilic asthma. Passively sensitized human isolated bronchi were challenged with the platelet-activating factor to reproduce ex vivo the hyperresponsiveness of airways of patients suffering from severe eosinophilic asthma. BNT162b2 was tested on the contractile sensitivity to histamine and parasympathetic activation via electrical field stimulation (EFS); some experiments were performed after mRNA denaturation. BNT162b2 increased the resting tone (+11.82 \u00b1 2.27%) and response to histamine in partially contracted tissue (+42.97 \u00b1 9.64%) vs. the control (p &lt; 0.001); it also shifted the concentration-response curve to histamine leftward (0.76 \u00b1 0.09 logarithm) and enhanced the response to EFS (+28.46 \u00b1 4.40%) vs. the control. Denaturation did not significantly modify (p &gt; 0.05) the effect of BNT162b2. BNT162b2 increases the contractile sensitivity to histamine and parasympathetic activation in hyperresponsive airways, a detrimental effect not related to the active component but to some excipient. A possible candidate for the bronchospasm elicited by BNT162b2 could be the polyethylene glycol\/macrogol used to produce LNP.<\/jats:p>","DOI":"10.3390\/vaccines11020282","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T05:57:23Z","timestamp":1675058243000},"page":"282","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The BNT162b2 mRNA COVID-19 Vaccine Increases the Contractile Sensitivity to Histamine and Parasympathetic Activation in a Human Ex Vivo Model of Severe Eosinophilic Asthma"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0456-069X","authenticated-orcid":false,"given":"Luigino","family":"Calzetta","sequence":"first","affiliation":[{"name":"Department of Medicine and Surgery, University of Parma, 43121 Parma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfredo","family":"Chetta","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, University of Parma, 43121 Parma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0636-5345","authenticated-orcid":false,"given":"Marina","family":"Aiello","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, University of Parma, 43121 Parma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annalisa","family":"Frizzelli","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, University of Parma, 43121 Parma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9877-7851","authenticated-orcid":false,"given":"Josuel","family":"Ora","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, University of Rome \u201cTor Vergata\u201d, 00133 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Melis","sequence":"additional","affiliation":[{"name":"Thoracic Surgery Unit, Regina Elena National Cancer Institute, 00144 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7137-8946","authenticated-orcid":false,"given":"Francesco","family":"Facciolo","sequence":"additional","affiliation":[{"name":"Thoracic Surgery Unit, Regina Elena National Cancer Institute, 00144 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Ippoliti","sequence":"additional","affiliation":[{"name":"Department of Biomedicine and Prevention, University of Rome \u201cTor Vergata\u201d, 00133 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Magrini","sequence":"additional","affiliation":[{"name":"Department of Biomedicine and Prevention, University of Rome \u201cTor Vergata\u201d, 00133 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7801-5040","authenticated-orcid":false,"given":"Paola","family":"Rogliani","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, University of Rome \u201cTor Vergata\u201d, 00133 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,28]]},"reference":[{"key":"ref_1","unstructured":"GINA (2022, September 13). 2022 GINA Main Report|Global Initiative for Asthma. Available online: https:\/\/ginasthma.org\/wp-content\/uploads\/2022\/07\/GINA-Main-Report-2022-FINAL-22-07-01-WMS.pdf."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1164\/rccm.201602-0419OC","article-title":"Inflammatory and Comorbid Features of Patients with Severe Asthma and Frequent Exacerbations","volume":"195","author":"Denlinger","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"9095275","DOI":"10.1155\/2018\/9095275","article-title":"Eosinophils from Physiology to Disease: A Comprehensive Review","volume":"2018","author":"Ramirez","year":"2018","journal-title":"BioMed Res. Int."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1465-9921-5-2","article-title":"Bronchospasm and its biophysical basis in airway smooth muscle","volume":"5","author":"Fredberg","year":"2004","journal-title":"Respir. Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e2122255","DOI":"10.1001\/jamanetworkopen.2021.22255","article-title":"Prevalence of Allergic Reactions After Pfizer-BioNTech COVID-19 Vaccination Among Adults With High Allergy Risk","volume":"4","author":"Shavit","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"ref_6","unstructured":"(2022, December 24). COVID-19 Vaccine Doses Administered by Manufacturer, European Union, (n.d.). Available online: https:\/\/ourworldindata.org\/grapher\/covid-vaccine-doses-by-manufacturer."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Caminati, M., Guarnieri, G., Batani, V., Scarpieri, E., Finocchiaro, A., Chieco-Bianchi, F., Senna, G., and Vianello, A. (2021). COVID-19 Vaccination in Patients with Severe Asthma on Biologic Treatment: Safety, Tolerability, and Impact on Disease Control. Vaccines, 9.","DOI":"10.3390\/vaccines9080853"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"140","DOI":"10.5414\/ALX02241E","article-title":"COVID-19 vaccination of patients with allergies and type-2 inflammation with concurrent antibody therapy (biologicals)\u2014A Position Paper of the German Society of Allergology and Clinical Immunology (DGAKI) and the German Society for Applied Allergo","volume":"5","author":"Pfaar","year":"2021","journal-title":"Allergol. Sel."},{"key":"ref_9","unstructured":"(2023, January 09). Global Initiative for Asthma GINA Global Strategy for Asthma Management and Prevention GINA Guidance about COVID-19 and Asthma. Available online: www.ginasthma.org."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1164\/rccm.202111-2496LE","article-title":"Reduced COVID-19 Vaccine Response in Patients Treated with Biologic Therapies for Asthma","volume":"205","author":"Runnstrom","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1164\/rccm.202203-0599LE","article-title":"SARS-CoV-2 mRNA Vaccine Antibody Response in Patients with Asthma Receiving Biologic Therapy: A Real-World Analysis","volume":"206","author":"Liao","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.3389\/fimmu.2022.892277","article-title":"Effectiveness and Durability of mRNA Vaccine-Induced SARS-CoV-2-Specific Humoral and Cellular Immunity in Severe Asthma Patients on Biological Therapy","volume":"13","author":"Podrazil","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1177\/00185787221111725","article-title":"Spontaneous Adverse Event Reporting by COVID-19 Vaccinated Healthcare Professionals Through an Electronic Form Implemented by the Hospital Pharmacy","volume":"57","author":"Carvalho","year":"2022","journal-title":"Hosp. Pharm."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.jaip.2020.12.047","article-title":"mRNA Vaccines to Prevent COVID-19 Disease and Reported Allergic Reactions: Current Evidence and Suggested Approach","volume":"9","author":"Banerji","year":"2021","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e2122326","DOI":"10.1001\/jamanetworkopen.2021.22326","article-title":"Allergic Reactions After COVID-19 Vaccination\u2014Putting Risk Into Perspective","volume":"4","author":"Phillips","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ijid.2021.09.026","article-title":"COVID vaccination and asthma exacerbation: Might there be a link?","volume":"112","author":"Colaneri","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e714","DOI":"10.1002\/ams2.714","article-title":"Can the coronavirus disease-2019 vaccine induce an asthma attack?","volume":"8","author":"Kawasaki","year":"2021","journal-title":"Acute Med. Surg."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.cmi.2021.09.018","article-title":"Real-world safety data for the Pfizer BNT162b2 SARS-CoV-2 vaccine: Historical cohort study","volume":"28","author":"Shasha","year":"2022","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/cea.12506","article-title":"Mechanisms of airway hyper-responsiveness in asthma: The past, present and yet to come","volume":"45","author":"Chapman","year":"2015","journal-title":"Clin. Exp. Allergy"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12931-018-0770-7","article-title":"Beclomethasone dipropionate and formoterol fumarate synergistically interact in hyperresponsive medium bronchi and small airways","volume":"19","author":"Calzetta","year":"2018","journal-title":"Respir. Res."},{"key":"ref_22","unstructured":"(2022, March 14). 2023 GOLD Reports-Global Initiative for Chronic Obstructive Lung Disease-GOLD, (n.d.). Available online: https:\/\/goldcopd.org\/2023-gold-report-2\/#."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ejphar.2005.12.043","article-title":"Inhibition of Rho-kinase normalizes nonspecific hyperresponsiveness in passively sensitized airway smooth muscle preparations","volume":"531","author":"Schaafsma","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1034\/j.1399-3003.1999.14b13.x","article-title":"Passive sensitization of human airways increases responsiveness to leukotriene C4","volume":"14","author":"Schmidt","year":"1999","journal-title":"Eur. Respir. J."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"L326","DOI":"10.1152\/ajplung.1994.267.3.L326","article-title":"Contraction of human bronchial smooth muscle caused by activated human eosinophils","volume":"267","author":"Rabe","year":"1994","journal-title":"Am. J. Physiol. Cell. Mol. Physiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1165\/ajrcmb.11.5.7946388","article-title":"Modulatory role of protein kinase C on the signal transduction pathway utilized by platelet-activating factor in eosinophil activation","volume":"11","author":"Kroegel","year":"1994","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1172\/JCI85664","article-title":"Lung-resident eosinophils represent a distinct regulatory eosinophil subset","volume":"126","author":"Mesnil","year":"2016","journal-title":"J. Clin. Investig."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1183\/09031936.02.00942001","article-title":"Studying human airway pharmacology in microsections: Application of videomicrometry","volume":"19","author":"Schmidt","year":"2002","journal-title":"Eur. Respir. J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1152\/jappl.1997.83.4.1276","article-title":"Passive sensitization of human airways induces myogenic contractile responses in vitro","volume":"83","author":"Mitchell","year":"1997","journal-title":"J. Appl. Physiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1183\/09031936.93.03010055","article-title":"The action of platelet activating factor and its antagonism by WEB 2086 on human isolated airways","volume":"3","author":"Johnson","year":"1990","journal-title":"Eur. Respir. J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1183\/09031936.93.05080970","article-title":"Platelet-activating factor-induced contraction of human isolated bronchus","volume":"5","author":"Johnson","year":"1992","journal-title":"Eur. Respir. J."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"4750","DOI":"10.1111\/bph.15240","article-title":"Targeting IL-5 pathway against airway hyperresponsiveness: A challenge between benralizumab and mepolizumab","volume":"177","author":"Calzetta","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1111\/bph.14909","article-title":"Beclomethasone dipropionate, formoterol fumarate and glycopyrronium bromide: Synergy of triple combination therapy on human airway smooth muscle ex vivo","volume":"177","author":"Rogliani","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0141-3910(94)00109-L","article-title":"Thermal degradation of poly(ethyleneglycol)","volume":"47","author":"Han","year":"1995","journal-title":"Polym. Degrad. Stab."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/ejhg.2013.145","article-title":"An efficient method for long-term room temperature storage of RNA","volume":"22","author":"Fabre","year":"2014","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1111\/j.1476-5381.2011.01339.x","article-title":"Epithelium integrity is crucial for the relaxant activity of brain natriuretic peptide in human isolated bronchi","volume":"163","author":"Matera","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1080\/17476348.2021.1979395","article-title":"Multi-walled carbon nanotubes induce airway hyperresponsiveness in human bronchi by stimulating sensory C-fibers and increasing the release of neuronal acetylcholine","volume":"15","author":"Calzetta","year":"2021","journal-title":"Expert Rev. Respir. Med."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Motulsky, H., and Christopoulos, A. (2004). Fitting Models to Biological Data Using Linear and Nonlinear Regression: A Practical Guide to Curve Fitting, Oxford University Press.","DOI":"10.1093\/oso\/9780195171792.001.0001"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.1111\/bph.14441","article-title":"Commentary on the BJP\u2019s new statistical reporting guidelines","volume":"175","author":"Motulsky","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"113910","DOI":"10.1016\/j.ejmech.2021.113910","article-title":"The nano delivery systems and applications of mRNA","volume":"227","author":"Li","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1056\/NEJMc2100766","article-title":"Maintaining Safety with SARS-CoV-2 Vaccines","volume":"384","author":"Rolla","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1111\/all.14711","article-title":"Allergic reactions to the first COVID-19 vaccine: A potential role of polyethylene glycol?","volume":"76","author":"Cabanillas","year":"2020","journal-title":"Allergy"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"100532","DOI":"10.1016\/j.waojou.2021.100532","article-title":"May polyethylene glycol be the cause of anaphylaxis to mRNA COVID-19 vaccines?","volume":"14","author":"Kalil","year":"2021","journal-title":"World Allergy Organ. J."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/cea.12760","article-title":"Immediate-type hypersensitivity to polyethylene glycols: A review","volume":"46","author":"Wenande","year":"2016","journal-title":"Clin. Exp. Allergy"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1600-0536.2012.02104.x","article-title":"A case of anaphylaxis caused by macrogol 3350 after injection of a corticosteroid","volume":"67","author":"Stockman","year":"2012","journal-title":"Contact Dermat."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jaip.2020.09.029","article-title":"Polyethylene Glycol\u2013Induced Systemic Allergic Reactions (Anaphylaxis)","volume":"9","author":"Sellaturay","year":"2021","journal-title":"J. Allergy Clin. Immunol. Pr."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40248-019-0189-0","article-title":"Efficacy and safety profile of doxofylline compared to theophylline in asthma: A meta-analysis","volume":"14","author":"Rogliani","year":"2019","journal-title":"Multidiscip. Respir. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"102125","DOI":"10.1016\/j.pupt.2022.102125","article-title":"Inflammatory and contractile profile in LPS-challenged equine isolated bronchi: Evidence for IL-6 as a potential target against AHR in equine asthma","volume":"73\u201374","author":"Calzetta","year":"2022","journal-title":"Pulm. Pharmacol. Ther."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Bhutani, M., Yang, W.H., H\u00e9bert, J., de Takacsy, F., and Stril, J.-L. (2017). The real world effect of omalizumab add on therapy for patients with moderate to severe allergic asthma: The ASTERIX Observational study. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0183869"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1152\/physiol.00050.2018","article-title":"Airway Innervation and Plasticity in Asthma","volume":"34","author":"Kistemaker","year":"2019","journal-title":"Physiology"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1056\/NEJMoa2110345","article-title":"Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months","volume":"385","author":"Thomas","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_52","unstructured":"CHMP (2022, January 21). Committee for Medicinal Products for Human Use (CHMP) Assessment Report Comirnaty Common Name: COVID-19 mRNA Vaccine (Nucleoside-Modified), (n.d.). Available online: www.ema.europa.eu\/contact."},{"key":"ref_53","unstructured":"Latypova, S. (2022, December 21). Did Pfizer Perform Adequate Safety Testing for Its Covid-19 mRNA Vaccine in Preclinical Studies? Evidence of Scientific and Regulatory Fraud. Available online: https:\/\/img1.wsimg.com\/blobby\/go\/d0283b38-61d3-48f6-bd2a-d67ae57c091a\/Review%20of%20Pfizer%27s%20Non-Clinical%20Program_Regula.pdf."},{"key":"ref_54","unstructured":"Palmer, M., and Bhakdi, S. (2022, December 21). The Pfizer mRNA Vaccine: Pharmacokinetics and Toxicity, Letsbfree.Com. Available online: https:\/\/letsbfree.com\/content\/uploads\/files\/2021\/10\/letsbfree_79fe2c12d77a388dc66e225bf18b3f2d.pdf."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1021\/nn101937h","article-title":"Effect of Core Diameter, Surface Coating, and PEG Chain Length on the Biodistribution of Persistent Luminescence Nanoparticles in Mice","volume":"5","author":"Maldiney","year":"2011","journal-title":"ACS Nano"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/PAF.0b013e31823d29ad","article-title":"Normal organ weights in men: Part II\u2014the brain, lungs, liver, spleen, and kidneys","volume":"33","author":"Molina","year":"2012","journal-title":"Am. J. Forensic Med. Pathol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/PAF.0000000000000175","article-title":"Normal organ weights in women: Part II\u2014The Brain, Lungs, Liver, Spleen, and Kidneys","volume":"36","author":"Molina","year":"2015","journal-title":"Am. J. Forensic Med. Pathol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"101849","DOI":"10.1016\/j.pupt.2019.101849","article-title":"Isolated airways in equine respiratory pharmacology: They never lie","volume":"59","author":"Calzetta","year":"2019","journal-title":"Pulm. Pharmacol. Ther."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"100010","DOI":"10.1016\/j.crphar.2020.100010","article-title":"Beclomethasone dipropionate and sodium cromoglycate protect against airway hyperresponsiveness in a human ex vivo model of cow\u2019s milk aspiration","volume":"2","author":"Ritondo","year":"2021","journal-title":"Curr. Res. Pharmacol. Drug Discov."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.rmed.2015.08.005","article-title":"Searching for the synergistic effect between aclidinium and formoterol: From bench to bedside","volume":"109","author":"Cazzola","year":"2015","journal-title":"Respir. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3109\/15412555.2014.922172","article-title":"Translational Study Searching for Synergy between Glycopyrronium and Indacaterol","volume":"12","author":"Cazzola","year":"2015","journal-title":"COPD: J. Chronic Obstr. Pulm. Dis."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"102050","DOI":"10.1016\/j.pupt.2021.102050","article-title":"Ceiling effect of beclomethasone\/formoterol\/glycopyrronium triple fixed-dose combination in COPD: A translational bench-to-bedside study","volume":"69","author":"Rogliani","year":"2021","journal-title":"Pulm. Pharmacol. Ther."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s40265-021-01480-7","article-title":"BNT162b2 mRNA COVID-19 Vaccine: First Approval","volume":"81","author":"Lamb","year":"2021","journal-title":"Drugs"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Yan, Z.-P., Yang, M., and Lai, C.-L. (2021). COVID-19 Vaccines: A Review of the Safety and Efficacy of Current Clinical Trials. Pharmaceuticals, 14.","DOI":"10.3390\/ph14050406"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"565","DOI":"10.2147\/JAA.S283489","article-title":"Potential Drawbacks of ICS\/LABA\/LAMA Triple Fixed-Dose Combination Therapy in the Treatment of Asthma: A Quantitative Synthesis of Safety Profile","volume":"15","author":"Rogliani","year":"2022","journal-title":"J. Asthma Allergy"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1080\/17476348.2021.1850275","article-title":"Reduced risk of COVID-19 hospitalization in asthmatic and COPD patients: A benefit of inhaled corticosteroids?","volume":"15","author":"Rogliani","year":"2021","journal-title":"Expert Rev. Respir. Med."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Aldakheel, F.M. (2021). Allergic Diseases: A Comprehensive Review on Risk Factors, Immunological Mechanisms, Link with COVID-19, Potential Treatments, and Role of Allergen Bioinformatics. Int. J. Environ. Res. Public Heal., 18.","DOI":"10.3390\/ijerph182212105"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.chest.2022.02.029","article-title":"Management of Life-Threatening Asthma","volume":"162","author":"Garner","year":"2022","journal-title":"Chest"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/11\/2\/282\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:17:40Z","timestamp":1760120260000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/11\/2\/282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,28]]},"references-count":68,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["vaccines11020282"],"URL":"https:\/\/doi.org\/10.3390\/vaccines11020282","relation":{},"ISSN":["2076-393X"],"issn-type":[{"type":"electronic","value":"2076-393X"}],"subject":[],"published":{"date-parts":[[2023,1,28]]}}}